These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 69186)

  • 1. Animal prolactin evidence for antipsychotic activity of piperoxane.
    Gold MS; Redmond DE; Donabedian RK
    Lancet; 1977 Jul; 2(8028):96-7. PubMed ID: 69186
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of piperoxane on serum prolactin: possible role of epinephrine-mediated synapses in the inhibition of prolactin secretion.
    Gold MS; Donabedian RK; Redmond DE
    Endocrinology; 1978 Apr; 102(4):1183-9. PubMed ID: 217617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of piperoxane on rat plasma prolactin.
    Meltzer HY; Fessler RG; Fang VS
    Commun Psychopharmacol; 1978; 2(3):237-42. PubMed ID: 212249
    [No Abstract]   [Full Text] [Related]  

  • 4. Increase in serum prolactin by exogenous and endogenous opiates: evidence for antidopamine and antipsychotic effects.
    Gold MS; Redmond DE; Donabedian RK; Goodwin FK; Extein I
    Am J Psychiatry; 1978 Nov; 135(11):1415-6. PubMed ID: 30292
    [No Abstract]   [Full Text] [Related]  

  • 5. Further evidence for alpha-2 adrenergic receptor mediated inhibition of prolactin secretion: the effect of yohimbine.
    Gold MS; Donabedian RK; Redmond DE
    Psychoneuroendocrinology; 1978 Oct; 3(3-4):253-60. PubMed ID: 219435
    [No Abstract]   [Full Text] [Related]  

  • 6. Decrease in serum prolactin by naloxone: evidence against antidopamine and antipsychotic effects.
    Gold MS; Pottash AL; Extein I; Redmond DE; Kleber HD
    Am J Psychiatry; 1979 Oct; 136(10):1339-40. PubMed ID: 114063
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased ouabain binding after repeated noradrenergic stimulation.
    Swann AC; Grant SJ; Jablons D; Maas JW
    Brain Res; 1981 Jun; 213(2):481-5. PubMed ID: 6265030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperoxane reduces the effects of clonidine on aggression in mice and on noradrenaline dependent hypermotility in rats.
    Buus Lassen J
    Eur J Pharmacol; 1978 Jan; 47(1):45-9. PubMed ID: 563333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Search for compounds with dopaminergic action. II. Synthesis of various derivatives of 6-aminomethyl-1,4-benzodioxane].
    Woliński J; Niemyjska M
    Acta Pol Pharm; 1985; 42(4):326-30. PubMed ID: 3834759
    [No Abstract]   [Full Text] [Related]  

  • 10. The pituitary dopamine receptor.
    Labrie F; Di Paolo T; Raymond V; Ferland L; Beaulieu M
    Adv Biochem Psychopharmacol; 1980; 23():217-27. PubMed ID: 6104906
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of cyclic and opened thioanalogues of piperoxan.
    Strappaghetti G; Brasili L
    Farmaco Sci; 1986 Oct; 41(10):794-800. PubMed ID: 2878824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perlapine: relationship between stimulation of prolactin secretion and antipsychotic activity.
    Meltzer HY; Fessler RG; Fang VS
    Psychopharmacology (Berl); 1977 Oct; 54(2):183-6. PubMed ID: 412213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supersensitivity of pituitary dopamine receptors involved in the inhibition of prolactin secretion.
    Annunziato L; Quattrone A; Schettini G; Di Renzo G
    Adv Biochem Psychopharmacol; 1980; 24():379-85. PubMed ID: 6105788
    [No Abstract]   [Full Text] [Related]  

  • 14. Antipsychotic agents and serum prolactin levels.
    JAMA; 1976 Nov; 236(19):2175. PubMed ID: 10453
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroleptic-induced supersensitivity psychosis.
    Chouinard G; Jones BD; Annable L
    Am J Psychiatry; 1978 Nov; 135(11):1409-10. PubMed ID: 30291
    [No Abstract]   [Full Text] [Related]  

  • 16. Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro.
    Bowden CR; Voina SJ; Woestenborghs R; De Coster R; Heykants J
    J Pharmacol Exp Ther; 1992 Aug; 262(2):699-706. PubMed ID: 1380082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of piperoxan and 2-(2-imidazolinyl)-1, 4-benzodioxane (170 150) on pre- and postsynaptic receptors in the rat].
    Mouillé P; Dabiré H; Fournier B; Schmitt H
    J Pharmacol; 1982; 13(3):389-97. PubMed ID: 6290793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorpromazine, haloperidol, metoclopramide and domperidone release prolactin through dopamine antagonism at low concentrations but paradoxically inhibit prolactin release at high concentrations.
    Besser GM; Delitala G; Grossman A; Stubbs WA; Yeo T
    Br J Pharmacol; 1980; 71(2):569-73. PubMed ID: 6110459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of vasopressin secretion by clonidine: effect of alpha-adrenoceptor antagonists.
    Reid IA; Nolan PL; Wolf JA; Keil LC
    Endocrinology; 1979 May; 104(5):1403-6. PubMed ID: 436784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational properties of benzodioxan derivatives with alpha-adrenergic blocking activity.
    Balsamo A; Macchia B; Macchia F; Martinelli A; Tognetti P; Veracini CA
    Mol Pharmacol; 1981 Sep; 20(2):371-6. PubMed ID: 6117787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.